Amgen Inc. (AMGN) vs Pfizer Inc. (PFE)
A side-by-side comparison of Amgen Inc. and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.
AMGN
Amgen Inc.
$375.65HealthcareDelayed quote: Sep 15, 2026, 4:00 PM EDT
PFE
Pfizer Inc.
$27.55HealthcareDelayed quote: Sep 15, 2026, 4:02 PM EDT
Total return — AMGN vs PFE
growth of $100 · dividends reinvested · last 10yAMGN +197.8% (+11.5%/yr)PFE +37.0% (+3.2%/yr)AMGN compounded faster over this window
AMGN PFE
AMGN vs PFE: by the numbers
- •AMGN is the larger company ($202.74B vs $157.02B market cap).
- •AMGN trades at the lower trailing earnings multiple (23.35 vs 36.40 P/E), one valuation lens rather than an overall verdict.
- •AMGN converts more revenue to profit (22.93% vs 6.81% net margin).
- •AMGN grew revenue faster over the past five years (8.39% vs 6.29% CAGR).
- •PFE pays the higher dividend yield (6.20% vs 2.63%).
Metrics side by side
Valuation
| Metric | AMGN | PFE |
|---|---|---|
| P/E ratio | 23.35 | 36.40 |
| Forward P/E | 16.28 | 9.26 |
| P/S ratio | 5.32 | 2.47 |
| P/B ratio | 17.35 | 1.84 |
| EV / EBITDA | N/A | 10.11 |
| FCF yield | 5.02% | 7.00% |
Profitability
| Metric | AMGN | PFE |
|---|---|---|
| Gross margin | 72.65% | 71.32% |
| Operating margin | 33.18% | 25.08% |
| Net margin | 22.93% | 6.81% |
| ROE | 74.80% | 5.09% |
| ROIC | 14.22% | 9.33% |
Dividends
| Metric | AMGN | PFE |
|---|---|---|
| Dividend yield | 2.63% | 6.20% |
| Payout ratio | 61.78% | 227.27% |
Growth (annualized)
| Metric | AMGN | PFE |
|---|---|---|
| Revenue CAGR (5Y) | 8.39% | 6.29% |
| EPS CAGR (5Y) | 2.94% | -3.78% |
| FCF CAGR (5Y) | -3.91% | -3.11% |
| Total return CAGR (5Y) | 15.58% | -4.53% |
Frequently asked
- Which has the lower trailing P/E, AMGN or PFE?
- AMGN has the lower trailing P/E: AMGN trades at 23.35 and PFE at 36.40. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, AMGN or PFE?
- Over the past five years, AMGN grew revenue faster — AMGN at a 8.39% CAGR versus PFE at 6.29%.
- Does AMGN or PFE pay a bigger dividend?
- AMGN yields 2.63% and PFE yields 6.20% based on trailing dividends and the latest price.
- Is AMGN or PFE more profitable?
- AMGN runs the higher net margin — AMGN at 22.93% versus PFE at 6.81%.
- How have AMGN and PFE total returns compared?
- Over the past 10 years, AMGN delivered 11.80% and PFE delivered 3.15% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Amgen P/E ratioPfizer P/E ratioAmgen dividend yieldPfizer dividend yieldAmgen ROEPfizer ROEAmgen operating marginPfizer operating marginAmgen revenue growthPfizer revenue growthAmgen free cash flowPfizer free cash flow
Amgen & Pfizer appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.